Form DEF 14A Minerva Neurosciences Inc For: 23 April
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Minerva Neurosciences Inc (NERV)
Assess today's live Minerva Neurosciences Inc (NERV) share price, performance and insights using our live NASDAQ: NERV stock exchange data.
Analyse the historical data and Minerva Neurosciences Inc share price performance charts on this page. Our technical summary section provides analysis on Minerva Neurosciences share price buy/sell indicators using real-time data (or discuss the Minerva Neurosciences (NERV) stock price today with other investors in the Minerva Neurosciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ NERV share price (ISIN: US6033802058) to enhance your trading decisions with our free investment tools and resources.
What Is the Minerva Neurosciences Inc Share Price Today?
The Minerva Neurosciences share price today is 6.440.
What Is the Stock Symbol for Minerva Neurosciences Inc
The stock symbol (or 'ticker') for Minerva Neurosciences Inc is "NERV."
What Stock Exchange Does Minerva Neurosciences Inc Trade On?
Minerva Neurosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Minerva Neurosciences Inc a Good Stock to Buy?
Determining whether Minerva Neurosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Minerva Neurosciences Inc share price performance charts on this page. Our technical summary section provides analysis on Minerva Neurosciences share price buy/sell indicators using real-time data (or discuss the Minerva Neurosciences (NERV) stock price today with other investors in the Minerva Neurosciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ NERV share price (ISIN: US6033802058) to enhance your trading decisions with our free investment tools and resources.
What Is the Minerva Neurosciences Inc Share Price Today?
The Minerva Neurosciences share price today is 6.440.
What Is the Stock Symbol for Minerva Neurosciences Inc
The stock symbol (or 'ticker') for Minerva Neurosciences Inc is "NERV."
What Stock Exchange Does Minerva Neurosciences Inc Trade On?
Minerva Neurosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Minerva Neurosciences Inc a Good Stock to Buy?
Determining whether Minerva Neurosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.240
6.505
52 wk Range
1.300
12.460
Earnings results expected in 8 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.2406.505
52 wk Range
1.30012.460
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NERV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
9.500
Upside
+47.52%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form 8K Minerva Neurosciences Inc For: 6 April
- Investing.com
- Minerva Neu receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Form DEF 14A Minerva Neurosciences Inc For: 23 April
- Investing.com
- Minerva Neu receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form PRE 14A Minerva Neurosciences Inc For: 10 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Compare NERV to Peers and Sector
Metrics to compare | NERV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNERVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −7.4x | −0.5x | |
PEG Ratio | 0.00 | −0.09 | 0.00 | |
Price/Book | −2.0x | 5.3x | 2.6x | |
Price / LTM Sales | - | 105.8x | 3.2x | |
Upside (Analyst Target) | 16.6% | 71.4% | 47.4% | |
Fair Value Upside | Unlock | 8.0% | 6.9% | Unlock |
Analyst Ratings
1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 9.500
(+47.52% Upside)
Earnings
Latest Release
11/03/2026
EPS / Forecast
-0.64 / -0.11
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Minerva Neurosciences (NASDAQ: NERV) Share Price Today?
The Minerva Neurosciences stock price today is 6.440 USD.
What Stock Exchange Does Minerva Neurosciences (NERV) Trade On?
Minerva Neurosciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Minerva Neurosciences?
The stock symbol (also called a 'ticker') for Minerva Neurosciences is "NERV."
What Is the Current Minerva Neurosciences Market Capitalisation?
As of today, Minerva Neurosciences (NASDAQ: NERV) market cap is 283.220M USD.
What Is Minerva Neurosciences's (NERV) Earnings Per Share (TTM)?
The Minerva Neurosciences EPS is currently -34.670 (Trailing Twelve Months).
When Is the Next Minerva Neurosciences Earnings Date?
Minerva Neurosciences's next earnings report will be released on 06/05/2026.
Is NERV a Buy or Sell From a Technical Analyst Perspective?
Based on today's Minerva Neurosciences moving averages and other technical indicators, the daily buy/sell signal for NERV stock is Neutral.
How Many Times Has Minerva Neurosciences Stock Split?
Minerva Neurosciences has split 1 times. (See the NERV stock split history page for full effective split date and price information.)
How Many Employees Does Minerva Neurosciences Have?
Minerva Neurosciences has 7 employees, based on their latest Companies House report.
What is the current trading status of Minerva Neurosciences (NASDAQ: NERV)?
As of 28/04/2026, Minerva Neurosciences (NERV) is trading at a share price of 6.440 USD, with a previous close of 6.430 USD. The stock has fluctuated within a day range of 6.240 USD to 6.505 USD, while its 52-week range spans from 1.300 USD to 12.460 USD.
What Is Minerva Neurosciences (NERV) Price Target According to Analysts?
The average 12-month price target for Minerva Neurosciences is 9.500 USD, with a high estimate of 14 USD and a low estimate of 7 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +47.52% Upside potential.
What Is the NERV Premarket Price?
NERV's last pre-market stock price is 6.520 USD. The pre-market share volume is 20.000, and the stock has decreased by 0.090, or 1.400%.
What Is the NERV After Hours Price?
NERV's last after hours stock price is 6.340 USD, the stock has decreased by -0.100, or -1.550%.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.